Company / EPS (Diluted)
Atara Biotherapeutics, Inc. EPS (Diluted) History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$11.41
FY2025
5-year range
-$65.19 / -$11.41
FY2024-FY2025
Trend
+82.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-11.41 in FY2025.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 82.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -73.54 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$11.41 | +82.5% |
| FY2024 | -$65.19 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026